Comparison of Meta-PENG and Suprainguinal Fascia Iliaca Plane Block in Hip Fractures

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

About this trial

This prospective observational single-center study will compare the effects of ultrasound-guided meta-PENG block and suprainguinal fascia iliaca plane block in patients undergoing hip fracture surgery under spinal anesthesia.

Hip fracture surgery can cause significant pain before, during, and after the operation. Regional anesthesia techniques may help reduce pain, improve positioning for spinal anesthesia, decrease the need for additional analgesics, and support earlier mobilization.

Patients included in the study will be adults scheduled for hip fracture surgery under spinal anesthesia. According to routine clinical practice and the anesthesiologist's decision, patients will receive either ultrasound-guided meta-PENG block or ultrasound-guided suprainguinal fascia iliaca plane block. The study will not assign patients to a treatment group by randomization.

The main outcome will be pain during positioning for spinal anesthesia, measured using the Numeric Rating Scale. Additional outcomes will include postoperative pain at rest and during activity, additional analgesic consumption, patient satisfaction, mobilization time, and length of hospital stay.

Eligibility criteria

Qualifiers

Age greater than 18 years

ASA physical status I-III

Scheduled to undergo hip fracture surgery under spinal anesthesia

Written informed consent obtained from the patient or the patient's legal representative

Disqualifiers

Refusal to participate in the study

ASA physical status IV-V

Presence of central or autonomic nervous system disease

Known allergy to the drugs used in the study

Trial design

Treatments tested in this trial

  • Ultrasound-Guided Meta-PENG Block
  • Ultrasound-Guided Suprainguinal Fascia Iliaca Plane Block

Treatment groups

80 Participants
are divided into 2 treatment groups